Bay State Biotech Report: Biogen, and Stalled M&A

Pharmaceutical and biotech acquisitions totaled $44 billion last quarter, down 13% from a year earlier. And we have a Biogen earnings summary. That’s all on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host Anne Mostue discuss the latest in biotech news from the Boston area and across the nation.

producer: Anne Mostue +1-617-210-4662 or amostue@bloomberg.net.

Running time 01:23

Before it's here, it's on the Bloomberg Terminal. LEARN MORE